| Campylobacter group| Campylobacteraceae| Campylobacteraceae Vandamme and De Ley 1991
Foodborne Infections: Campylobacter species are a leading cause of bacterial gastroenteritis worldwide, commonly acquired through the consumption of contaminated food, particularly undercooked poultry, unpasteurized milk, and contaminated water.
Gastrointestinal Symptoms: Infections with Campylobacter can lead to symptoms such as diarrhea, abdominal cramps, fever, and vomiting. The illness is usually self-limiting, but severe cases may require medical attention.
Post-Infection Complications: In some cases, Campylobacter infections have been associated with post-infection complications, including the development of Guillain-BarrΓ© syndrome (GBS), a rare neurological disorder that can lead to muscle weakness and paralysis.
Zoonotic Transmission: Campylobacteraceae bacteria are often present in the intestines of animals, especially poultry, and can be transmitted to humans through the consumption of contaminated food products or direct contact with infected animals.
Antibiotic Resistance: There are growing concerns about antibiotic resistance in Campylobacter species, which may complicate the treatment of severe infections.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.96 | 0 | 0 | 10 | 38545 | 0 | 16437 | 3425 | 690 | 6638.8 | 0 | 6150 | 0 %ile | 100 %ile |
biomesight | 38.47 | 0 | 20 | 10 | 250 | 0 | 7412 | 615.5 | 50 | 3467.6 | 0 | 250 | 0 %ile | 89.4 %ile |
thorne | 100 | 110 | 5117 | 0 | 3894 | 1298.5 | 693 | 1324.4 | 83 | 3211 | 0 %ile | 100 %ile | ||
thryve | 38.36 | 0 | 26 | 18 | 13871 | 0 | 4208 | 504.2 | 61 | 1889.8 | 0 | 297 | 8 %ile | 99.1 %ile |
ubiome | 33.59 | 0 | 48 | 12 | 798 | 0 | 16976 | 1977.9 | 143 | 7652.1 | 0 | 931 | 0 %ile | 92 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 97.13 | 344.46 | 0.0097 | 0.0344 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 40 % | 0.724 % | 1.541 % | 6.0 | 15 |
BiomeSight | 40.922 % | 0.07 % | 0.368 % | 1172.0 | 2864 |
BiomeSightRdp | 21.875 % | 0.076 % | 0.159 % | 7.0 | 32 |
bugspeak | 100 % | 0.021 % | % | 1.0 | 1 |
CerbaLab | 66.667 % | 0.013 % | 0.011 % | 2.0 | 3 |
CosmosId | 9.375 % | 0.024 % | 0.035 % | 3.0 | 32 |
custom | 45.763 % | 0.914 % | 0.749 % | 27.0 | 59 |
es-xenogene | 96.552 % | 0.196 % | 0.126 % | 28.0 | 29 |
Medivere | 100 % | 0.005 % | 0.003 % | 7.0 | 7 |
SequentiaBiotech | 19.444 % | 0.151 % | 0.112 % | 7.0 | 36 |
Thorne | 85.556 % | 0.076 % | 0.102 % | 77.0 | 90 |
Thryve | 38.106 % | 0.045 % | 0.177 % | 527.0 | 1383 |
Tiny | 100 % | 0.001 % | % | 1.0 | 1 |
uBiome | 33.46 % | 0.198 % | 0.765 % | 265.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.